Asthma and COPD 2018 is a conference dedicated to concepts driving the developments of asthma and COPD forward, including:
- Clinical trial design and strategies for method enhancement
- Treatment for exacerbations
- Anti-inflammatory developments
- Biomarkers and the utilisation of devices for Asthma and COPD
- Current regulatory requirements
- Efficacy and toxicological issues relating to combination products
Who should Attend
Chief Scientific Officers, Chief Executives, Vice Presidents, Chief Medical Officers, Directors, Heads, Principle Scientists, Senior Scientist, Physicians, Clinicians, Specialists, Project Leaders and Managers in areas such as:
- Respiratory Pharmacology
- Respiratory Physiology & Medicine
- Inflammatory Disease
- Regulatory and Medical Affairs
- Pulmonary Disease
- Respiratory, Inflammation and Autoimmunity
- Immunology
- Respiratory Therapeutics
- In-Vitro Biology
- Medical & Inhalation Devices
- Inflammation Discovery
- Biomarker
- Clinical Pharmacology
- Preclinical R&D
- Research and Development
- Clinical Trials
- Brand Manager
- Business Development
- Respiratory
- Commercial
